Kuros Biosciences AG
CSBTFOTCHealthcare● Active
$26.00
+$1.25(+5.05%)
Market Cap$1.0B
P/E Ratio—
52W High$42.81
52W Low$24.75
Kuros Biosciences AG（CSBTF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CSBTF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.12B | $0.08B | $0.03B | $0.02B | $0.01B |
| Cost of Revenue | $0.02B | $0.01B | $0.01B | $0.01B | $0.00B |
| Gross Profit | $0.10B | $0.06B | $0.03B | $0.01B | $0.01B |
| Gross Margin %(computed) | 86.39% | 82.10% | 84.83% | 59.87% | 72.86% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| G&A Expenses | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.10B | $0.07B | $0.04B | $0.02B | $0.02B |
| Operating Income | $0.01B | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | 6.04% | -6.61% | -39.30% | -74.76% | -63.46% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Income Before Tax | $0.00B | ($0.00B) | ($0.01B) | ($0.02B) | ($0.01B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Net Income | $0.00B | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Net Margin %(computed) | 1.75% | -4.92% | -40.90% | -81.15% | -54.59% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.06 | $-0.10 | $-0.38 | $-0.43 | $-0.23 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.04B | 0.03B | 0.03B |
| EBITDA | $0.01B | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) |
| EBITDA Margin %(computed) | 8.35% | -0.74% | -22.33% | -41.70% | -38.30% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CHF · B
深入了解Kuros Biosciences AG
关于Kuros Biosciences AG（CSBTF）损益表
Kuros Biosciences AG（CSBTF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CSBTF实现营收$0.12B，毛利润$0.10B（毛利率86.39%），净利润$0.00B（净利率1.75%）。
常见问题
CSBTF · 4 问Kuros Biosciences AG（CSBTF）2025财年营收为$0.12B，同比up60.6%。
CSBTF revenueCSBTF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09